Filtern nach Last updated date SelectDanachVorFrom - To Date Enddatum Diese Woche Diesen Monat Letzte Woche Letzter Monat Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Bitte dieses Feld leer lassen Filter Ergebnisse (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Bitte dieses Feld leer lassen EMA recommends withdrawal of marketing authorisation for amfepramone medicines 10 Juni 2022NewsHumanMedicines EMA publishes annual report 2021 10 Juni 2022NewsHumanVeterinaryCorporate EMA adopts first list of critical medicines for COVID-19 8 Juni 2022NewsHumanCOVID-19 EMA business hours over Whit Monday holiday, 6 June 2 Juni 2022NewsCorporateCOVID-19 EMA appoints Chief Medical Officer 1 Juni 2022NewsCorporateGovernance EMA business hours over Ascension Day holidays, 26 and 27 May 24 Mai 2022NewsCorporateCOVID-19 EMA guidance supports development of new antibiotics 24 Mai 2022NewsHumanRegulatory and procedural guidancePaediatrics Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022 20 Mai 2022NewsHumanCOVID-19Medicines First therapy to treat rare genetic nervous system disorder AADC deficiency 20 Mai 2022NewsHumanMedicines Synchron Research Service: suspension of medicines over flawed studies 20 Mai 2022NewsHumanPharmacovigilanceReferrals 1 … 44 45 46 47 48 Page 48 of 383 49 50 51 52 … 383
EMA recommends withdrawal of marketing authorisation for amfepramone medicines 10 Juni 2022NewsHumanMedicines
EMA guidance supports development of new antibiotics 24 Mai 2022NewsHumanRegulatory and procedural guidancePaediatrics
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022 20 Mai 2022NewsHumanCOVID-19Medicines
First therapy to treat rare genetic nervous system disorder AADC deficiency 20 Mai 2022NewsHumanMedicines
Synchron Research Service: suspension of medicines over flawed studies 20 Mai 2022NewsHumanPharmacovigilanceReferrals